The Global Radiotherapy Market is expected to exceed more than US$ 8.50 Billion by 2022 at a CAGR of 6.8% in the given forecast period.
November 20, 2018 —
New York, November 20, 2018: Every day new innovations are been made in every field and in healthcare lot of research and development is going on but for cancer till date radiotherapy is considered as most effective treatment overall for killing the cancer disease. A Cancer patient who uses beams of high energy radiation to kill cancer cells in the body is known as radiotherapy treatment. Radiotherapy is infrequently used to treat mild tumors and different conditions, for example, thyroid ailment and some blood disorders. Radiotherapy is utilized alone or in mix with chemotherapy (chemo radiotherapy) to treat cancer tumor. Symptoms of cancer can be effectively controlled by radiotherapy. Radiotherapy might be utilized before surgery or after surgery to decimate small tumor cells that might be cleared out.
The Global Radiotherapy Market is expected to exceed more than US$ 8.50 Billion by 2022 at a CAGR of 6.8% in the given forecast period.
You Can Browse Full Report: https://www.marketresearchengine.com/radiotherapy-market-report
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Accuray Incorporated (U.S.), Ion Beam Applications SA (Belgium), C. R. Bard, Inc. (U.S.), IsoRay Medical, Inc. (U.S.), Varian Medical Systems, Inc. (U.S.), Nordion, Inc. (Canada), Elekta AB (Sweden), RaySearch Laboratories AB (Sweden), Mevion Medical Systems, Inc. (U.S.), and Mitsubishi Electric Corporation (Japan).Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The scope of the report includes a detailed study of global and regional markets on Global Radiotherapy Market with the reasons given for variations in the growth of the industry in certain regions.
The Global Radiotherapy Market has been segmented as below: (Accordingly)
The Global Radiotherapy Market is Segmented on the lines of Technology Analysis, Product Analysis, Application Analysis and Regional Analysis. By Technology Analysis this market is segmented on the basis of External Beam Radiation Therapy its covers Image-Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Technology, Proton Beam Therapy, Tomotherapy, 3D Conformal Radiotherapy (3D CRT) & Volumetric Modulated Arc Therapy (VMAT). Internal Beam Radiotherapy its covers Low Dose Rate & High Dose Rate. And Systemic Radiation Therapy. By Product Analysis this market is segmented on the basis of External beam radiation therapy its covers Compact Advanced Radiotherapy Systems likes Cyberknife, Gamma Knife & Tomotherapy. Proton Therapy Systems likes Cyclotron & Synchrotron. And Electron Emitting High Energy Linear Accelerators (Linac). Internal Radiation Therapy/Brachytherapy its covers Seeds, Applicators & Afterloaders & Electronic Brachytherapy. And Systemic Radiation Therapy.
By Application Analysis this market is segmented on the basis of External Beam Radiation Therapy its covers Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer, Colorectal Cancer & Other. Internal Radiation Therapy its covers Prostate Cancer, Gynecological Cancer, Breast Cancer, Penile Cancer & Other. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.
This report provides:
1) An overview of the global market for Global Radiotherapy Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Global Radiotherapy Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The restraining factors of Global Radiotherapy Market are as follows:
Absence of adequate infrastructure
Visualizing Tumors is complex
Trained personnel shortage
Strict rules and regulations regarding healthcare
The major driving factors of Global Radiotherapy Market are as follows:
Growing number of cancer patients and disease.
Technological innovations
Adoption of Radiotherapy Devices and Procedures are in raise
Driving Investments in Radiotherapy due to increase in demand for cancer treatment
Rapidly growing geriatric population
Spreading Awareness About the Benefits of Radiotherapy
Request Sample Report from here: https://www.marketresearchengine.com/radiotherapy-market-report
Table of Contents
1 INTRODUCTION
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Radiotherapy Market, By Product
7 Radiotherapy Market, By Technology
8 Global Radiotherapy Market, By Application
9 Radiotherapy Market, By Region
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia-Pacific
9.5 Rest of the World (RoW)
9.5.1 Latin America
9.5.2 Middle East
9.5.3 Africa
10 Competitive Landscape
11 Company Profiles
11.1 Varian Medical Systems, Inc.
11.2 Elekta AB
11.3 Accuray Incorporated
11.4 IBA (ION Beam Applications SA)
11.5 Nordion, Inc.
11.6 C. R. Bard, Inc.
11.7 Isoray Medical, Inc.
11.8 Raysearch Laboratories
11.9 Mitsubishi Electric Corporation
11.10 Mevion Medical Systems, Inc.
11.11 Theragenics Corporation
11.12 P-Cure Ltd.
11.13 Viewray Inc.
11.14 Panacea Medical Technologies Pvt. Ltd.
11.15 Pronova Solutions, LLC.
Other Related Market Research Reports:
Revenue Cycle Management Market is Expected to Get US$ 45.50 Billion By 2022
Public Safety Analytics Market is Expected to Exceed US$ 12.50 Billion by 2024
Smart Food Labels Market Overview and Forecast by 2022: KeyPlayers, Region, Types, Applications
Contact Info:
Name: John Bay
Email: Send Email
Organization: Market Research Engine
For more information, please visit https://www.marketresearchengine.com/
Release ID: 447392
